In a filing, Niagen Bioscience Inc revealed its SVP, General Counsel Lopez Carlos Luis acquired Company’s shares for reported $2146.0 on Mar 07 ’25. In the deal valued at $7.86 per share,273 shares were bought. As a result of this transaction, Lopez Carlos Luis now holds 2,251 shares worth roughly $26516.78.
Then, Jaksch Frank L Jr sold 37,161 shares, generating $229,956 in total proceeds. Upon selling the shares at $6.19, the Director now owns 244,179 shares.
Before that, Frank Jaksch Jr. bought 37,161 shares. Niagen Bioscience Inc shares valued at $229,961 were divested by the affiliate at a price of $6.19 per share.
Canaccord Genuity initiated its Niagen Bioscience Inc [NAGE] rating to a Buy in a research note published on May 27, 2025; the price target was $13. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who decreased its forecast for the stock in mid August from “an Outperform” to “a Perform”. B. Riley Securities also remained covering NAGE and has decreased its forecast on August 11, 2022 with a “Neutral” recommendation from previously “Buy” rating. ROTH Capital started covering the stock on March 08, 2022. It rated NAGE as “a Buy”.
Price Performance Review of NAGE
On Tuesday, Niagen Bioscience Inc [NASDAQ:NAGE] saw its stock jump 0.43% to $11.78. Over the last five days, the stock has gained 11.13%. Niagen Bioscience Inc shares have risen nearly 122.05% since the year began. Nevertheless, the stocks have risen 316.25% over the past one year. While a 52-week high of $11.79 was reached on 06/03/25, a 52-week low of $2.31 was recorded on 01/07/25. SMA at 50 days reached $8.24, while 200 days put it at $6.03.
Levels Of Support And Resistance For NAGE Stock
The 24-hour chart illustrates a support level at 11.41, which if violated will result in even more drops to 11.05. On the upside, there is a resistance level at 11.99. A further resistance level may holdings at 12.21. The Relative Strength Index (RSI) on the 14-day chart is 73.93, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.72, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 2.99%. Stochastics %K at 92.81% indicates the stock is a selling.
How much short interest is there in Niagen Bioscience Inc?
A steep rise in short interest was recorded in Niagen Bioscience Inc stocks on 2025-05-15, growing by 72996.0 shares to a total of 2.2 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 2.13 million shares. There was a rise of 3.32%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 16, 2019 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $6 price target.
